‘Project NextGen’ picks new mRNA, intranasal COVID vaccines for funding

‘Project NextGen’ picks new mRNA, intranasal COVID vaccines for funding

Source: 
BioPharma Dive
snippet: 

The awards, to biotechs Gritstone, Codagenix and CastleVax, are part of the federal program’s plan to develop vaccines with broader or longer-lasting benefits.